Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) announced its earnings results on Tuesday. The company reported ($2.00) earnings per share for the quarter, missing the consensus estimate of $0.19 by ($2.19), Zacks reports. The firm had revenue of $314.39 million during the quarter, compared to the consensus estimate of $303.21 million. Guardian Pharmacy Services updated its FY 2024 guidance to EPS.
Guardian Pharmacy Services Stock Performance
GRDN stock traded down $0.07 during midday trading on Friday, reaching $20.93. The company had a trading volume of 68,722 shares, compared to its average volume of 157,017. Guardian Pharmacy Services has a fifty-two week low of $14.16 and a fifty-two week high of $23.05.
Insider Buying and Selling at Guardian Pharmacy Services
In related news, Director Thomas J. Salentine, Jr. bought 35,714 shares of the firm's stock in a transaction on Friday, September 27th. The stock was bought at an average cost of $14.00 per share, for a total transaction of $499,996.00. Following the completion of the purchase, the director now directly owns 35,714 shares in the company, valued at approximately $499,996. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Analyst Upgrades and Downgrades
GRDN has been the subject of several recent analyst reports. Truist Financial raised their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a "buy" rating in a research note on Friday. Raymond James started coverage on Guardian Pharmacy Services in a research note on Monday, October 21st. They set an "outperform" rating and a $21.00 target price for the company. Finally, Stephens started coverage on Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They issued an "overweight" rating and a $21.00 price target for the company.
Check Out Our Latest Stock Analysis on Guardian Pharmacy Services
Guardian Pharmacy Services Company Profile
(
Get Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Further Reading
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
